Literature DB >> 23507717

Medical ICU admission diagnoses and outcomes in human immunodeficiency virus-infected and virus-uninfected veterans in the combination antiretroviral era.

Kathleen M Akgün1, Janet P Tate, Margaret Pisani, Terri Fried, Adeel A Butt, Cynthia L Gibert, Laurence Huang, Maria C Rodriguez-Barradas, David Rimland, Amy C Justice, Kristina Crothers.   

Abstract

OBJECTIVES: Human immunodeficiency virus (HIV)-infected (HIV+) patients on combination antiretroviral therapy are living longer but have increased risk for aging-associated disease which may lead to increasing critical care requirements. We compare medical ICU admission characteristics and outcomes among HIV infected and demographically similar uninfected patients (uninfected) and considered whether an index which combines routine clinical biomarkers (the Veterans Aging Cohort Study Index) predicts 30-day medical ICU mortality.
DESIGN: Observational data analyses (Veterans Aging Cohort Study).
SETTING: Eight Veterans Affairs medical centers nationwide. PATIENTS: HIV infected and uninfected with a medical ICU admission between 2002 and 2010. INTERVENTION: None.
MEASUREMENTS AND MAIN RESULTS: Medical ICU admission was determined using bedsection (Veterans Affairs) and revenue center codes (Medicare). For Veterans Affairs admissions, we used clinical data to calculate Veterans Aging Cohort Study Index scores and multivariable logistic regression to determine factors associated with 30-day mortality. Overall, 539 of 3,620 (15%) HIV infected and 375 of 3,639 (10%) uninfected had a medical ICU admission; 72% and 78%, respectively, were Veterans Affairs based. HIV+ patients were younger at admission (p < 0.0001). Although most HIV+ patients were on antiretroviral therapy (71%) with undetectable HIV-1 RNA (54%), compared with uninfected they were more commonly admitted with respiratory diagnoses or infections (21% vs. 12%), were more likely to require mechanical ventilation (17% vs. 9%; p = 0.001), and had a higher mortality rate (18.6% vs. 11.2%, p = 0.003). Cardiovascular diagnoses were less common among HIV infected (18% vs. 29%; p < 0.0001). In logistic regression (c-statistic 0.87), a 5-point increment in Veterans Aging Cohort Study Index was associated with an odds ratio of death of 1.22 (95% confidence interval 1.14-1.30) among HIV infected and of 1.50 (95% confidence interval 1.29-1.76) among uninfected; infection/sepsis and respiratory diagnoses were also associated with mortality.
CONCLUSIONS: Medical ICU admission was frequent, 30-day mortality higher, and mechanical ventilation more common in HIV infected compared with uninfected. The Veterans Aging Cohort Study Index calculated at medical ICU admission predicted 30-day mortality for HIV infected and uninfected. As more individuals age with HIV, their requirements for medical ICU care may be greater than demographically similar uninfected individuals.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23507717      PMCID: PMC4283206          DOI: 10.1097/CCM.0b013e31827caa46

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  46 in total

Review 1.  A primer and comparative review of major US mortality databases.

Authors:  Diane C Cowper; Joseph D Kubal; Charles Maynard; Denise M Hynes
Journal:  Ann Epidemiol       Date:  2002-10       Impact factor: 3.797

2.  The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine.

Authors:  J L Vincent; R Moreno; J Takala; S Willatts; A De Mendonça; H Bruining; C K Reinhart; P M Suter; L G Thijs
Journal:  Intensive Care Med       Date:  1996-07       Impact factor: 17.440

3.  APACHE II: a severity of disease classification system.

Authors:  W A Knaus; E A Draper; D P Wagner; J E Zimmerman
Journal:  Crit Care Med       Date:  1985-10       Impact factor: 7.598

4.  The validity of self-reported smoking: a review and meta-analysis.

Authors:  D L Patrick; A Cheadle; D C Thompson; P Diehr; T Koepsell; S Kinne
Journal:  Am J Public Health       Date:  1994-07       Impact factor: 9.308

5.  Effect of highly active antiretroviral therapy on hospitalization characteristics of HIV-infected patients.

Authors:  R Nuesch; N Geigy; E Schaedler; M Battegay
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2002-09-06       Impact factor: 3.267

6.  ICU survival of patients with the acquired immunodeficiency syndrome.

Authors:  R M Schein; M A Fischl; A E Pitchenik; C L Sprung
Journal:  Crit Care Med       Date:  1986-12       Impact factor: 7.598

7.  Impact of HAART advent on admission patterns and survival in HIV-infected patients admitted to an intensive care unit.

Authors:  Enrique Casalino; Michel Wolff; Philippe Ravaud; Christophe Choquet; Fabrice Bruneel; Bernard Regnier
Journal:  AIDS       Date:  2004-07-02       Impact factor: 4.177

8.  Intensive care in patients with HIV infection in the era of highly active antiretroviral therapy.

Authors:  Mangala Narasimhan; Adam J Posner; Vera A DePalo; Paul H Mayo; Mark J Rosen
Journal:  Chest       Date:  2004-05       Impact factor: 9.410

9.  A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study.

Authors:  J R Le Gall; S Lemeshow; F Saulnier
Journal:  JAMA       Date:  1993 Dec 22-29       Impact factor: 56.272

10.  Intensive care of patients with the acquired immunodeficiency syndrome. Outcome and changing patterns of utilization.

Authors:  R M Wachter; J M Luce; J Turner; P Volberding; P C Hopewell
Journal:  Am Rev Respir Dis       Date:  1986-11
View more
  35 in total

1.  Opportunistic Infections and Mortality: Still Room for Improvement.

Authors:  Henry Masur; Sarah W Read
Journal:  J Infect Dis       Date:  2015-06-03       Impact factor: 5.226

2.  Markers of chronic obstructive pulmonary disease are associated with mortality in people living with HIV.

Authors:  Matthew Triplette; Amy Justice; Engi F Attia; Janet Tate; Sheldon T Brown; Matthew Bidwell Goetz; Joon W Kim; Maria C Rodriguez-Barradas; Guy W Soo Hoo; Cherry Wongtrakool; Kathleen Akgün; Kristina Crothers
Journal:  AIDS       Date:  2018-02-20       Impact factor: 4.177

3.  An adapted frailty-related phenotype and the VACS index as predictors of hospitalization and mortality in HIV-infected and uninfected individuals.

Authors:  Kathleen M Akgün; Janet P Tate; Kristina Crothers; Stephen Crystal; David A Leaf; Julie Womack; Todd T Brown; Amy C Justice; Krisann K Oursler
Journal:  J Acquir Immune Defic Syndr       Date:  2014-12-01       Impact factor: 3.731

4.  Prevalence and Predictors of Hospitalizations Among HIV-Infected and At-Risk HIV-Uninfected Women.

Authors:  Anna L Hotton; Kathleen M Weber; Ronald C Hershow; Kathryn Anastos; Peter Bacchetti; Elizabeth T Golub; Deborah Gustafson; Alexandra M Levine; Mary Young; Mardge H Cohen
Journal:  J Acquir Immune Defic Syndr       Date:  2017-06-01       Impact factor: 3.731

5.  Medical Intensive Care Unit Admission Among Patients With and Without HIV, Hepatitis C Virus, and Alcohol-Related Diagnoses in the United States: A National, Retrospective Cohort Study, 1997-2014.

Authors:  Christopher T Rentsch; Janet P Tate; Tessa Steel; Adeel A Butt; Cynthia L Gibert; Laurence Huang; Margaret Pisani; Guy W Soo Hoo; Stephen Crystal; Maria C Rodriguez-Barradas; Sheldon T Brown; Matthew S Freiberg; Christopher J Graber; Joon W Kim; David Rimland; Amy C Justice; David A Fiellin; Kristina A Crothers; Kathleen M Akgün
Journal:  J Acquir Immune Defic Syndr       Date:  2019-02-01       Impact factor: 3.731

6.  Temporal trends in critical events complicating HIV infection: 1999-2010 multicentre cohort study in France.

Authors:  François Barbier; Antoine Roux; Emmanuel Canet; Patricia Martel-Samb; Philippe Aegerter; Michel Wolff; Bertrand Guidet; Elie Azoulay
Journal:  Intensive Care Med       Date:  2014-09-19       Impact factor: 17.440

7.  Albumin, white blood cell count, and body mass index improve discrimination of mortality in HIV-positive individuals.

Authors:  Janet P Tate; Jonathan A C Sterne; Amy C Justice
Journal:  AIDS       Date:  2019-04-01       Impact factor: 4.177

8.  Opioid use trajectory groups and changes in a physical health biomarker among HIV-positive and uninfected patients receiving opioid agonist treatment.

Authors:  Kathleen A McGinnis; David A Fiellin; Melissa Skanderson; Yih-Ing Hser; Gregory M Lucas; Amy C Justice; Janet P Tate
Journal:  Drug Alcohol Depend       Date:  2019-09-04       Impact factor: 4.492

9.  Improved Outcomes in Critically Ill Patients With AIDS: How Does This Trend Continue?

Authors:  Daniel A Sweeney; Kevan Akrami; Atul Malhotra
Journal:  Crit Care Med       Date:  2016-02       Impact factor: 7.598

10.  The Effect of Substance Use Disorders on the Association Between Guideline-concordant Long-term Opioid Therapy and All-cause Mortality.

Authors:  Julie R Gaither; Joseph L Goulet; William C Becker; Stephen Crystal; E Jennifer Edelman; Kirsha Gordon; Robert D Kerns; David Rimland; Melissa Skanderson; Amy C Justice; David A Fiellin
Journal:  J Addict Med       Date:  2016 Nov/Dec       Impact factor: 3.702

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.